Companies that own Fagron N.V.
JPMorgan Asset Management (UK) Ltd.
3,728,945
5.19%
165,912
0.06%
07/26/2018
Evermore Global Advisors LLC
2,203,472
3.07%
0
5.61%
12/31/2017
Teslin Capital Management BV
1,140,822
1.59%
925,533
3.06%
09/30/2016
BNP Paribas Asset Management Belgium SA
577,978
0.8%
0
0.1%
07/31/2018
Thompson, Siegel & Walmsley LLC
539,148
0.75%
19,500
0.07%
01/31/2018
BlackRock Fund Advisors
418,390
0.57%
253
0%
09/06/2018
Thornburg Investment Management, Inc.
360,449
0.5%
9,202
0.02%
03/31/2018
Dimensional Fund Advisors LP
350,070
0.49%
-12,920
0%
04/30/2018
BLI - Banque de Luxembourg Investments SA
272,400
0.38%
0
0.06%
07/31/2018
Assenagon Asset Management SA (Germany)
248,871
0.35%
248,871
0.03%
06/29/2018
| Address |
Venecoweg 20A
Nazareth VL 9810
Belgium
|
|
Employees
|
- |
| Website |
http://www.fagron.com |
| Updated |
07/08/2019 |
| Fagron NV engages in the provision of development, marketing, and distribution of healthcare products and services. It operates through the following segments: Fagron Specialty Pharma Services (FSPS); Fagron Trademarks (FTM); Fagron Essentials (FE); and HL Technology. The FSPS segment refers to all personalized medication that is prepared in sterile and non-sterile compounding facilities in Europe, the United States, Colombia and South Africa. |
